- Home
- AMTB vs COLL Comparison
AMTB vs COLL Comparison
Compare AMTB & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTB
- COLL
- Stock Information
- Founded
- AMTB 1979
- COLL 2002
- Country
- AMTB United States
- COLL United States
- Employees
- AMTB N/A
- COLL N/A
- Industry
- AMTB Major Banks
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- AMTB Finance
- COLL Health Care
- Exchange
- AMTB Nasdaq
- COLL Nasdaq
- Market Cap
- AMTB 837.4M
- COLL 958.8M
- IPO Year
- AMTB N/A
- COLL 2015
- Fundamental
- Price
- AMTB $21.51
- COLL $38.16
- Analyst Decision
- AMTB Buy
- COLL Strong Buy
- Analyst Count
- AMTB 4
- COLL 4
- Target Price
- AMTB $24.00
- COLL $44.25
- AVG Volume (30 Days)
- AMTB 178.5K
- COLL 444.8K
- Earning Date
- AMTB 10-22-2025
- COLL 08-07-2025
- Dividend Yield
- AMTB 1.67%
- COLL N/A
- EPS Growth
- AMTB N/A
- COLL N/A
- EPS
- AMTB 0.09
- COLL 1.06
- Revenue
- AMTB $305,477,000.00
- COLL $707,007,000.00
- Revenue This Year
- AMTB $62.62
- COLL $22.23
- Revenue Next Year
- AMTB $6.74
- COLL $2.78
- P/E Ratio
- AMTB $238.23
- COLL $36.64
- Revenue Growth
- AMTB N/A
- COLL 22.61
- 52 Week Low
- AMTB $16.21
- COLL $23.23
- 52 Week High
- AMTB $26.24
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- AMTB 68.40
- COLL 63.49
- Support Level
- AMTB $21.25
- COLL $37.29
- Resistance Level
- AMTB $20.60
- COLL $39.10
- Average True Range (ATR)
- AMTB 0.50
- COLL 0.93
- MACD
- AMTB 0.15
- COLL -0.06
- Stochastic Oscillator
- AMTB 93.37
- COLL 54.26
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.